Ikarian Capital, LLC Trillium Therapeutics Inc. Call Options Transaction History

Ikarian Capital, LLC

  • $714 Million
  • Q1 2025

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 14, 2022
SELL
N/A
-198,400 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
N/A
-1,600 Reduced 0.8%
198,400 $3.48 Million
Q4 2020

Feb 12, 2021
BUY
N/A
200,000 New
200,000 $2.94 Million

About Trillium Therapeutics Inc.

TRIL Quotes by TradingView
  • Ticker TRIL
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,995,000
  • Market Cap $1.94B
More about TRIL
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email